EVX2

Across TCGA pan-cancer cohorts, EVX2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated EVX2 data layer compared with 8 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher EVX2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EVX2 expression acts as an unfavorable survival marker, although some lineages such as UCS and PRAD show a favorable association.

COAD, ACC, and LGG are the cancer types where EVX2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Quartile	All	0.304	0.614	<.001	81	view →
ACC	DFS	Tertile	All	0.366	0.731	<.001	77	view →
LGG	DFS	Median	All	0.665	0.808	<.001	54	view →
CHOL	OS	Tertile	All	0.019	0.800	<.001	54	view →
STAD	OS	Tertile	All	0.618	0.770	<.001	49	view →
BLCA	DFS	Quartile	IV	0.213	0.446	.005	47	view →
UVM	DFS	Tertile	III,IV	0.215	0.727	.001	45	view →
LUAD	DFS	Tertile	III,IV	0.322	0.549	.006	38	view →
KIRC	DFS	Quartile	All	0.543	0.691	.008	24	view →
LIHC	OS	Tertile	III,IV	0.337	0.636	.010	21	view →
UCS	DFS	Quartile	II,III,IV	0.522	0.199	.012	20	view →
ESCA	DFS	Tertile	III,IV	0.260	0.504	.024	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

EVX2–COAD (DFS)

Open the COAD breakdown →